misonidazole has been researched along with Carcinoma, Anaplastic in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, YM; Kuge, Y; Nishikawa, Y; Okamoto, S; Onimaru, R; Peng, H; Shiga, T; Shirato, H; Takeuchi, W; Tamaki, N; Tsuchiya, K; Watanabe, S; Yasuda, K | 1 |
| Fu, M; Lv, B; Qiu, J; Wang, X; Zheng, X; Zhuo, W | 1 |
| Baxi, S; Beattie, B; Boyle, J; Chan, S; Ganly, I; Humm, J; Katabi, N; Lanning, R; Lee, N; Li, D; McBride, S; Mitrani, L; Morris, LG; Pfister, DG; Riaz, N; Schoder, H; Sherman, E; Wong, R; Yarusi, B; Zhang, Z | 1 |
| Ametamey, S; Honer, M; Jochum, W; Oehler, C; Pruschy, M; Riesterer, O | 1 |
| Byhardt, RW; Cox, JD; Greenberg, M; Komaki, R | 1 |
| Anderson, PJ; Bennett, MH; Dische, S; Saunders, MI | 1 |
| Brown, DM; Brown, JM; Lee, WW; Yu, NY | 1 |
| Arnold, EP; Bailey, C; Burry, AF; Bydder, PV; Firth, LA; Gowland, S; Gray, AJ; Mcllroy, R | 1 |
| Denekamp, J; Hirst, DG; Stewart, FA; Terry, NH | 1 |
| Bundy, BN; Creasman, WT; d'Ablaing, G; Fowler, WC; Keys, HM; Mortel, R; Stehman, FB; Thomas, G | 1 |
| Chang, CW; Chen, KY; Chou, KL; Liu, RS; Wu, LC; Yang, DJ; Yeh, SH; Yen, SH; Yu, TW | 1 |
| Chang, CP; Chang, CW; Chen, KY; Chou, KL; Chu, LS; Liu, RS; Lui, MT; Wu, LC; Yeh, SH; Yen, SH | 1 |
| Giuliano, J; Lee, DJ; Moini, M; Westra, WH | 1 |
| Banáth, JP; Durand, RE; Olive, PL | 1 |
| Siemann, DW; Sutherland, RM | 1 |
| Murray, JC; Randhawa, VS | 1 |
| Denekamp, J; Hermeking, H; Kummermehr, J; Lindenberger, J | 1 |
| Rose, MA; Shipley, WU | 1 |
1 review(s) available for misonidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Hypoxic sensitizer and cytotoxin for head and neck cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Hypoxia; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Etanidazole; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mice; Microelectrodes; Misonidazole; Oxygen Consumption; Radiation Tolerance; Radiation-Sensitizing Agents; Survival Rate; Tirapazamine; Treatment Outcome; Triazines | 1996 |
4 trial(s) available for misonidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Oxygen; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tumor Hypoxia | 2016 |
Primary tumor control after radiotherapy for carcinoma of the bronchus.
Topics: Bronchial Neoplasms; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Double-Blind Method; Humans; Misonidazole; Neoplasm Metastasis; Nitroimidazoles; Radiation Tolerance | 1984 |
A national trial on the treatment of invasive bladder cancer.
Topics: Carcinoma; Clinical Trials as Topic; Humans; Misonidazole; Nausea; Neoplasm Staging; New Zealand; Nitroimidazoles; Urinary Bladder Neoplasms; Vomiting | 1981 |
Hydroxyurea versus misonidazole with radiation in cervical carcinoma: long-term follow-up of a Gynecologic Oncology Group trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Cause of Death; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Hydroxyurea; Life Tables; Middle Aged; Misonidazole; Recurrence; Survival Analysis; Uterine Cervical Neoplasms | 1993 |
13 other study(ies) available for misonidazole and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors.
Topics: Adult; Aged; Carcinoma; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2017 |
Topics: Adult; Carcinoma; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Sampling Studies; Treatment Outcome; Tumor Burden | 2017 |
Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
Topics: Animals; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Glucose Transporter Type 1; Humans; Immunohistochemistry; Mammary Neoplasms, Animal; Mice; Misonidazole; Neoplasm Transplantation; Neovascularization, Pathologic; Phthalazines; Positron-Emission Tomography; Pyridines; Transplantation, Homologous | 2006 |
Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors.
Topics: Adenocarcinoma; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Misonidazole; Mouth Neoplasms; Nitroimidazoles; Oropharynx; Pharyngeal Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Retrospective Studies | 1980 |
SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
Topics: Animals; Carcinoma; Cell Line; Central Nervous System; Cricetinae; Dogs; Etanidazole; Female; In Vitro Techniques; Lipid Metabolism; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Sarcoma, Experimental; X-Rays | 1981 |
Is tumour radiosensitization by misonidazole a general phenomenon?
Topics: Animals; Carcinoma; Cell Line; Dose-Response Relationship, Radiation; Male; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation Tolerance; Sarcoma, Experimental; Time Factors | 1980 |
Fluorine-18 fluoromisonidazole tumour to muscle retention ratio for the detection of hypoxia in nasopharyngeal carcinoma.
Topics: Carcinoma; Case-Control Studies; Cell Hypoxia; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; Misonidazole; Nasopharyngeal Neoplasms; Nasopharynx; Neck Muscles; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 1996 |
Detection of anaerobic odontogenic infections by fluorine-18 fluoromisonidazole.
Topics: Bacteria, Anaerobic; Bacterial Infections; Carcinoma; Case-Control Studies; Cell Hypoxia; Dental Caries; Dental Pulp Diseases; Fluorine Radioisotopes; Humans; Misonidazole; Nasopharyngeal Neoplasms; Periodontal Diseases; Predictive Value of Tests; Radiation-Sensitizing Agents; Sensitivity and Specificity; Tomography, Emission-Computed | 1996 |
The range of oxygenation in SiHa tumor xenografts.
Topics: Animals; Carcinoma; Cell Survival; Comet Assay; DNA Damage; Female; Humans; In Vitro Techniques; Mice; Mice, Inbred NOD; Mice, SCID; Misonidazole; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Transplantation, Heterologous; Uterine Cervical Neoplasms | 2002 |
Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Topics: Animals; Antineoplastic Agents; Aziridines; Bone Marrow; Carcinoma; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Lomustine; Mice; Mice, Inbred C3H; Mice, Inbred Strains; Misonidazole; Nitrofurans; Radiation-Sensitizing Agents; Sarcoma, Experimental; Stem Cells; Tumor Cells, Cultured | 1992 |
Misonidazole reduces blood flow in two experimental murine tumours.
Topics: Animals; Blood Volume; Carcinoma; Depression, Chemical; Kidney; Mice; Mice, Inbred Strains; Misonidazole; Muscles; Regional Blood Flow; Sarcoma, Experimental; Skin; Time Factors | 1988 |
Response of human tumour xenografts to fractionated X-irradiation.
Topics: Animals; Carcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Radiation; Female; Humans; Male; Mice; Mice, Nude; Misonidazole; Mouth Neoplasms; Neoplasm Transplantation; Photochemotherapy; Radiotherapy Dosage; Tonsillar Neoplasms; Transplantation, Heterologous | 1986 |
Bladder cancer. The selection of patients for treatment by full-dose irradiation.
Topics: Brachytherapy; Carcinoma; Cisplatin; Combined Modality Therapy; Humans; Misonidazole; Prognosis; Radiotherapy Dosage; Radiotherapy, High-Energy; Urinary Bladder; Urinary Bladder Neoplasms | 1985 |